Follitropin
- Generic Name
- Follitropin
- Brand Names
- Bemfola, Follistim, Gonal F, Gonal-F, Menopur, Ovaleap, Pergoveris, Puregon, GONAL-f, Rekovelle
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 146479-72-3
- Unique Ingredient Identifier
- 2M2GGL7HUP
- Background
Follitropin is a human follicle stimulating hormone (FSH) preparation of recombinant DNA origin, which consists of two non-covalently linked, non-identical glycoproteins designated as the alpha- and beta- subunits. The alpha- and beta- subunits have 92 and 111 amino acids. The alpha subunit is glycosylated at Asn 51 and Asn 78 while the beta subunit is glyco...
- Indication
In women having been diagnosed with primary ovarian failure, it is used in combination with human chorionic gonadotropin (hCG) to assist in ovulation and fertility. In men with hypogonadotrophic hypogonadism, it is used to induce spermatogenesis. Follitropin may also be used to cause the ovary to produce several follicles, which can then be harvested for use...
- Associated Conditions
- -
- Associated Therapies
- Assisted Reproductive Technology therapy, Controlled Ovarian Stimulation
An Exploratory Study to Investigate the Effect of FE 999302 When Given Together With Follitropin Delta at Different Time Intervals During Controlled Ovarian Stimulation.
- Conditions
- Interventions
- First Posted Date
- 2024-07-22
- Last Posted Date
- 2024-11-26
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 200
- Registration Number
- NCT06511791
- Locations
- 🇪🇸
Ferring Investigational Site, Valencia, Spain
Possible Action of Resveratrol in Improving the Outcomes of IVF/ICSI in Couples With Unexplained Infertility
- Conditions
- Interventions
- First Posted Date
- 2024-07-01
- Last Posted Date
- 2024-07-01
- Lead Sponsor
- Andros Day Surgery Clinic
- Target Recruit Count
- 90
- Registration Number
- NCT06481696
- Locations
- 🇮🇹
ANDROS Day Surgery Clinic, Palermo, Italy
An Exploratory Study to Investigate the Effect of FE 999302 When Given Together With Follitropin Delta During Controlled Ovarian Stimulation
- Conditions
- Interventions
- First Posted Date
- 2024-06-20
- Last Posted Date
- 2024-12-20
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 600
- Registration Number
- NCT06466486
- Locations
- 🇪🇸
Ferring Investigational Site, Valencia, Spain
Use of Pulsatile Intravenous FSH to Mitigate Reprometabolic Syndrome
- First Posted Date
- 2024-05-16
- Last Posted Date
- 2024-11-27
- Lead Sponsor
- University of Colorado, Denver
- Target Recruit Count
- 5
- Registration Number
- NCT06414096
- Locations
- 🇺🇸
University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States
Retrospective Study of High Dose Follitropin Delta in a Mixed Protocol With Human Chorionic Gonadotropin
- First Posted Date
- 2023-05-24
- Last Posted Date
- 2023-10-31
- Lead Sponsor
- Clinique Ovo
- Target Recruit Count
- 150
- Registration Number
- NCT05873725
- Locations
- 🇨🇦
Clinique Ovo, Montreal, Quebec, Canada
Continuous Double Ovarian Stimulation.
- Conditions
- Interventions
- First Posted Date
- 2023-04-18
- Last Posted Date
- 2023-04-18
- Lead Sponsor
- Instituto Bernabeu
- Target Recruit Count
- 30
- Registration Number
- NCT05815719
- Locations
- 🇪🇸
Instituto Bernabeu, Alicante, Spain
Effect of LH Supplementation on the Endometrial Gene Expression Profile in Poor Ovarian Responders
- Conditions
- Interventions
- First Posted Date
- 2022-06-06
- Last Posted Date
- 2024-02-28
- Lead Sponsor
- CRG UZ Brussel
- Registration Number
- NCT05405686
Real-world Evidence on Follitropin Delta Individual Dosing
- First Posted Date
- 2021-12-30
- Last Posted Date
- 2024-12-05
- Lead Sponsor
- University of Luebeck
- Target Recruit Count
- 850
- Registration Number
- NCT05173597
- Locations
- 🇩🇪
University of Luebeck, Luebeck, Schleswig-Holstein, Germany
Cumulative Pregnancy Rate With Lower and Higher Gonadotropin Dose During IVF Among Poor Responders
- Conditions
- Interventions
- First Posted Date
- 2021-11-02
- Last Posted Date
- 2024-12-13
- Lead Sponsor
- Peter Kovacs MD
- Target Recruit Count
- 190
- Registration Number
- NCT05103228
- Locations
- 🇭🇺
Dunamenti REK Reprodukciós Központ, Budapest, Hungary
Estradiol and Progesterone Levels Following Frozen Embryo Transfer
- Conditions
- Interventions
- First Posted Date
- 2021-08-09
- Last Posted Date
- 2024-05-14
- Lead Sponsor
- Copenhagen University Hospital at Herlev
- Target Recruit Count
- 300
- Registration Number
- NCT04997525
- Locations
- 🇩🇰
Herlev University Hospital, Herlev, Denmark
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.